Opening book details…
About this Medicine article
3107 A phase I/II study of erlotinib, carboplatin, pemetrexed and bevacizumab in chemotherapy-naïve patients with advanced nonsquamous non-small-cell lung cancer harboring EGFR mutations by Yokoi, T.; Kurata, T.; Torii, Y.; Katashiba, Y.; Satsutani, N.M.; Nomura, S. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Yokoi, T.; Kurata, T.; Torii, Y.; Katashiba, Y.; Satsutani, N.M.; Nomura, S.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Yokoi, T.; Kurata, T.; Torii, Y.; Katashiba, Y.; Satsutani, N.M.; Nomura, S.
Browse all works by Yokoi, T.; Kurata, T.; Torii, Y.; Katashiba, Y.; Satsutani, N.M.; Nomura, S.